Michelle Booden, Salk’s senior director of licensing and intellectual property, addressed Salkexcellerators’ fall forum in November with stories of how commercialized Salk technologies impacted diseases that affect human health. Salkexcellerators are the next generation of community members committed to supporting scientific discovery at the Institute. The 10-year-old program provides social and educational events throughout the year and supports a fellowship fund for the Institute’s postdoctoral researchers.